Evaluation of radiogallium-labeled, folate-embedded superparamagnetic nanoparticles in fibrosarcoma-bearing mice

Seyyedeh Leila Hosseini-Salekdeh1, Amir Reza Jalilian, Hassan Yousefnia

  • 1Department of Engineering and Technical, Science and Research Branch, Islamic Azad University, Tehran, 14778-93855, Iran.

Abstract

Insights

This study developed gallium-67 labeled superparamagnetic iron oxide nanoparticles (67Ga-SPION-folate) for targeted cancer imaging. The nanoparticles showed promising tumor accumulation in mice, indicating potential for advanced diagnostics and therapeutics.

Area of Science:

  • Nanotechnology
  • Radiopharmaceuticals
  • Oncology

Background:

  • Folate receptors (FR) are overexpressed in many human cancers.
  • Folate targeting is a key strategy for cancer drug delivery, particularly with nano-radioactive agents.

Purpose of the Study:

  • To produce and biologically evaluate gallium-67 labeled superparamagnetic iron oxide nanoparticles embedded with folic acid (67Ga-SPION-folate).
  • To assess the potential of 67Ga-SPION-folate for tumor imaging in tumor-bearing mice.

Main Methods:

  • SPION-folate structure confirmed by XRD, TEM, and FT-IR.
  • Radiolabeling efficiency assessed by ITLC.
  • Particle size determined to be approximately 5-10 nm.
  • Biocompatibility evaluated using MTT assay.
  • In vivo studies conducted in fibrosarcoma-bearing mice.

Main Results:

  • The 67Ga-SPION-folate nanoparticles were successfully prepared with >95% radiochemical purity.
  • Particle size was confirmed to be in the 5-10 nm range.
  • Biodistribution studies showed significant tumor accumulation with high tumor-to-background ratios (e.g., tumor:muscle ratio of 11.54 at 24 h).

Conclusions:

  • The developed 67Ga-SPION-folate nano-complex exhibits nano-scale size and high tumor-targeting capabilities.
  • This system holds potential as a drug delivery modality for cancer therapy.
  • The paramagnetic properties also suggest applications in thermotherapy.

Related Concept Videos